Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT02221427 |
| Other study ID # |
LAPS3293 |
| Secondary ID |
|
| Status |
Active, not recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
December 2014 |
| Est. completion date |
December 2025 |
Study information
| Verified date |
November 2023 |
| Source |
Ostfold Hospital Trust |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The purpose of this study is to evaluate if the rate of emergency caesarean section can be
reduced if adhering to a dynamic labour progression curve compared to a static progression
curve for first time mothers without jeopardising maternal and neonatal outcomes
Description:
1. Introduction The increasing rate of emergency caesarean sections in developed countries
is of great concern as it is associated with adverse outcomes for mother and infant. The
rate of caesarean sections for first time mothers with a singleton foetus in a vertex
position and spontaneous onset of labour at term has increased from 5.7 % to 9.2 % in
Norway. The most common indication for emergency caesarean sections is Labour dystocia,
even if there is no consensus on criteria for the diagnosis.
Labour dystocia is characterised by abnormally slow progress of labour and is among the
most common challenges of birth care especially in first time mothers. When the labour
progression is assessed to be prolonged according to current guidelines, labour dystocia
is treated by amniotomy followed by oxytocin infusion to augment uterus contractions.
Oxytocin is a potent drug and classified by the Institute for Safe Medication Practices
in the USA as one of 12 medications which is "bearing heightened risk of harm".
In Norway the guidelines for expected progression of labour is based on modifications of
Friedman's curve of cervical dilatation, a linear labour progression curve developed in
1953. Contemporary research by Zhang shows that the dilatation of the cervix can be
substantially slower than earlier expected, especially at an early stage of labour.
Hypothesis: By adhering to the guideline for labour progression presented by Zhang, the
rate of emergency caesarean sections in first time mothers will decrease compared to
adhering to the guideline for labour progression based on a modified Friedman's curve,
without jeopardising the maternal and neonatal outcomes.
2. Background and status of knowledge Traditionally the labour process is divided in two
stages; the first stage and the second stage. The first stage is divided in two phases;
the latent phase and the active phase, the latent phase is defined from onset of labour
until the cervix is dilated four centimetres with 3-4 painful contractions per ten
minutes. The active phase is defined from a cervix dilatation of four centimetres until
fully dilated. The second stage is divided in two phases; the deceleration phase where
the baby's head is decelerating towards the pelvic floor and the expulsion phase where
the mother is actively pushing the baby out.
To visualize the progression of labour, the status of the cervix dilatation is
traditionally measured and recorded throughout labour on a graphic curve often called a
partogram. The partogram is widely used internationally and facilitates that midwives'
and doctors' can monitor labour progression, and together with criteria for labour
dystocia, consequently carry out necessary interventions.
In 1954 Dr. Friedman presented the first progression curve based on examination of 100
first time mothers. Friedman's curve has been widely adopted and applied in practice
internationally for almost 60 years. In 2002 Dr. Zhang presented a new labour curve
based on labour data from 1329 low-risk women. Zhang's findings were confirmed in a
large cohort of 26,838 women in 2010.
Zhang's labour curve differs markedly from the Friedman's curve in that the cervix
dilates substantially slower, especially before reaching six centimetres of dilatation,
nor is the distinct deflection of the curve between nine and ten centimetres in
Friedman's curve found in Zhang's curve. These findings may suggest that the diagnostic
criteria for labour dystocia are too stringent following Friedman's curve in
contemporary birth care.
A new guideline for normal birth progression is developed according to Zhang's curve and
contemporary research findings. The new guideline differs from the existing ones by not
expecting a linear progression and by defining the progression to be normal if the speed
of cervical dilatation is within the 95 percentile of the duration in Zhang's material.
Active labour is defined when the cervical dilatation is 4 centimetres or more until the
baby is born. In this dynamic labour curve, labour dystocia is defined if time from 4 to
5 cm exceeds six hours and 30 minutes, if time from 5 to 6 cm exceeds three hours and 15
minutes, if time from 6 to 7 cm exceeds two hour and 15 minutes, if time from 7 to 8 cm
exceeds one hour and 30 minutes, if time from 8 to 9 cm exceeds one hour and 30 minutes
or if time from 9 to 10 cm exceeds one hour and 45 minutes.
New knowledge and competence on labour progression may result in a new guideline
allowing low-risk labours to proceed without unnecessary interventions which will
benefit the population both medically and economically.
3. Design and implementation To evaluate if our hypothesis is true, a cluster randomised
trial will be conducted. The objective is to include birth care units by randomising
them to adhere to either of the two guidelines in active labour; F (Standard care
according to Friedman's guideline) or Z; (Experimental care according to Zhang's
guideline) F = Guideline with the following expected labour progression: if the cervix
dilates at least 1 centimetre per hour assessed after 4 hours. Labour dystocia is
diagnosed if progression proceeds slower than this definition throughout the active
phase of the first stage of labour. Labour dystocia in the second stage of labour is
diagnosed if lasting longer than two hours, three hours for women with epidurals or if
the expulsion phase lasts longer than 60 minutes. This guideline is based on an
interpretation of Friedman's expected progression of labour.
Z = Guideline which takes into account the dilatation of the cervix on admission and
calculates the expected progression during the active phase of the first stage of labour
based on this finding. Labour dystocia in the second stage of labour is diagnosed if lasting
longer than two hours and 45 minutes, three hours and 30 minutes for women with epidurals or
if the expulsion phase lasts longer than 60 minutes. This guideline is based on the labour
progression curve by Zhang.
Fourteen clusters will be included. The choice of cluster randomising, is due to the risk of
contamination if randomised on an individual level. Key elements to specify regarding
allocation of treatment are: The method of generating the allocation sequence is
computer-generated, the allocation ratio is equal to one, and the type of randomisation is
restricted and the factors "size of birth care unit" and "prior rates of caesarean sections
for first time mothers with a singleton foetus in a vertex position, in spontaneous onset of
labour at term" will be used for stratification.
The randomisation process will be performed through a central computer assisted programme.
The trial will be conducted according to the CONSORT statement for planning and
implementation of cluster randomised trials.
All clusters will receive a concise edition of the trial protocol and sign the cooperation
agreement.
Each cluster must also provide one dedicated person (local coordinator) responsible for the
trial during the inclusion period. The local coordinator is responsible for recruitment and
inclusion of participants, monitoring the entries in a web-Case Report Form (web-CRF), record
control of each participant and is responsible for the implementation of the trial.
For each included cluster, all the following criteria must be met: Birth care units that are
willing to adhere to the guidelines in the trial period and who consider that they have the
capacity to participate both logistical and practical. The size of the birth care units
should be more than 500 deliveries per year to secure a reasonable inclusion period.
Statistical methods and data analysis: The determination of the sample size is based on a
power calculation with the least occurring outcome; emergency caesarean section, which is 9.2
% in the study population (p1). Further, we expect that the emergency caesarean section rate
will be 6.7 % (p2) which id a 25 % reduction, when using the new guideline. With a chosen
significance level of 0.05, a power of 80 % and p1=9.2 % and p2=6.9 %, we will have to
include at least 14 clusters and 6582 individuals. As we are testing a new guideline,
blinding of care givers is not possible. The statistician will perform analyses blinded to
the participant's affiliation to the groups as a control of the analysis.
Analysis: The difference between the randomized groups will be presented with a Risk Ratio
(RR) and a 95 % confidence interval (95% CI). For dichotomous efficacy variables a
significance test taking into account the cluster structure of the data, will be used. For
continuous data an independent sample t-test will be used. Statistical analysis will be
conducted using STATA version 10.1 StataCorp, Texas, //845 USA and SPSS version 18. The
analyses will be conducted according to the principle of intention to treat.
Implementation All first time mothers with a singleton foetus in a vertex position, in
spontaneous onset of labour at term will adhere to the labour progression guideline that the
cluster is randomised to.
All eligible participants will receive written information about the trial when called for
routine ultrasound control, at the routine ultrasound control or at the labour ward. They
will be asked to sign an informed consent permitting her data to be included in the analyses,
and to answer an on-line questionnaire about her childbirth experience.
Safety assessment: All women in both arms will be cared for and monitored according to the
procedures at each birth care unit. Necessary interventions due to the mother's or the fetus'
needs, will be conducted regardless of the allocated guideline for labour progression.
Web-Case Report Form: Due to different systems for electronic medical records and due to
additional handwritten records, a web based Case Report Form (web-CRF) is being designed by
the Unit of Applied Clinical Research at the Faculty of Medicine at the Norwegian University
of Science and Technology, NTNU. The web-CRF is transferable to the analytical tools; STATA
and SPSS. The local coordinators will ensure that the data required by the protocol is
entered de-identified into the web-CRF. The local coordinators are also responsible for
assuring that data entered into the web-CRF is complete, accurate, and that entry is
performed in a timely manner. The signature of the local coordinators will attest to the
accuracy of the data on each web-CRF.
Consecutively assessments will be recorded in the electronic journal throughout labour,
assessments recorded on the printed version of the partogram will be transmitted to the
web-CRF at each birth care unit. Assessments to be recorded throughout labour are e.g.:
Cervix status on admission (in centimetres), results of regularly vaginal exploration, the
use of oxytocin, pain relief and additional interventions.
The trial manager shall arrange for the secure retention of the participant identification
and the code list. Participant files shall be kept for the maximum period of time permitted
by each birth care unit. The trial documentation (web-CRF, Site File etc.) shall be retained
and stored during the trial and for 10 years after trial closure. All information concerning
the trial will be stored in a safe place inaccessible to unauthorized personnel.
Investigator Delegation Procedure: The trial manager is responsible for making and updating a
"delegation of tasks" listing all the involved co-workers and their role in the project. The
principle investigators will ensure that appropriate training relevant to the study is given
to the staff, and that any new information of relevance to the performance of this trial is
forwarded to the staff involved.
All significant protocol deviations will be recorded and reported in the Clinical Study
Report (CSR).
If it is necessary for the study protocol to be amended, the amendment and/or a new version
of the trial protocol (Amended Protocol) must be notified to and approved by the Competent
Authority and the Ethics Committees according to EU and national regulations.
Audit and Inspections: Authorized representatives of a Competent Authority and Ethics
Committee may visit the centres to perform inspections, including source data verification.
The purpose of an inspection is to systematically and independently examine all study-related
activities and documents to determine whether these activities were conducted, and data were
recorded, analysed, and accurately reported according to the protocol, Good Clinical
Practice, and any applicable regulatory requirements. The principal investigators will ensure
that the inspectors and auditors will be provided with access to source data/documents.
Publication policy: All personnel who have contributed significantly with the planning and
performance of the study according to the Vancouver convention 1988 may be included in the
list
Ethical and regulatory requirements: The trial will be conducted in accordance with ethical
principles that have their origin in the Declaration of Helsinki and are consistent with Good
Clinical Practice and applicable regulatory requirements. Registration of participant's data
will be carried out in accordance with national personal data laws. The protocol, including
the patient information and informed consent form to be used, is approved by the ethics
committee in Norway: 2013/1862/REK sør-øst. The principal investigator is responsible for
informing the ethics committee of any serious and unexpected adverse events and/or major
amendments to the protocol as per national requirements.
The protocol must be approved by the management at the birth care units before commencement
of the trial. The protocol will also be registered in www.clinicaltrials.gov before
enrollment of participants.
